Genetic polymorphisms of the human MDR1 drug transporter

被引:234
作者
Schwab, M
Eichelbaum, M
Fromm, MF
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[2] Univ Tubingen Hosp, Div Clin Pharmacol, D-72076 Tubingen, Germany
关键词
P-glycoprotein; ABC transporter; pharmacogenetics; drug disposition; pharmacogenomics;
D O I
10.1146/annurev.pharmtox.43.100901.140233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P-glycoprotein is an ATP-dependent efflux pump that contributes to the protection of the body from environmental toxins. It transports a huge variety of structurally diverse compounds. P-glycoprotein is involved in limiting absorption of xenobiotics from the gut lumen, in protection of sensitive tissues (brain, fetus, testis), and in biliary and urinary excretion of its substrates. P-glycoprotein can be inhibited or induced by xenobiotics, thereby contributing to variable drug disposition and drug interactions. Recently, several SNPs have been identified in the MDR1 gene, some of which can affect P-glycoprotein expression and function. Potential implications of MDR1 polymorphisms for drug disposition, drug effects, and disease risk are discussed.
引用
收藏
页码:285 / 307
页数:23
相关论文
共 110 条
[81]   DISRUPTION OF THE MOUSE MDR1A P-GLYCOPROTEIN GENE LEADS TO A DEFICIENCY IN THE BLOOD-BRAIN-BARRIER AND TO INCREASED SENSITIVITY TO DRUGS [J].
SCHINKEL, AH ;
SMIT, JJM ;
VANTELLINGEN, O ;
BEIJNEN, JH ;
WAGENAAR, E ;
VANDEEMTER, L ;
MOL, CAAM ;
VANDERVALK, MA ;
ROBANUSMAANDAG, EC ;
TERIELE, HPJ ;
BERNS, AJM ;
BORST, P .
CELL, 1994, 77 (04) :491-502
[82]   ABSENCE OF THE MDR1A P-GLYCOPROTEIN IN MICE AFFECTS TISSUE DISTRIBUTION AND PHARMACOKINETICS OF DEXAMETHASONE, DIGOXIN, AND CYCLOSPORINE-A [J].
SCHINKEL, AH ;
WAGENAAR, E ;
VANDEEMTER, L ;
MOL, CAAM ;
BORST, P .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1698-1705
[83]   Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene [J].
Schuetz, EG ;
Yasuda, K ;
Arimori, K ;
Schuetz, JD .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 350 (02) :340-347
[84]   P-glycoprotein: A major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans [J].
Schuetz, EG ;
Schinkel, AH ;
Relling, MV ;
Schuetz, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4001-4005
[85]  
SCHWAB M, 2002, IN PRESS GUT
[86]   Crohn's disease [J].
Shanahan, F .
LANCET, 2002, 359 (9300) :62-69
[87]   Single-nucleotide polymorphisms can cause different structural folds of mRNA [J].
Shen, LX ;
Basilion, JP ;
Stanton, VP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) :7871-7876
[88]   THE STRUCTURE OF AN RNA PSEUDOKNOT THAT CAUSES EFFICIENT FRAMESHIFTING IN MOUSE MAMMARY-TUMOR VIRUS [J].
SHEN, LX ;
TINOCO, I .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 247 (05) :963-978
[89]  
Shon J, 2002, CLIN PHARMACOL THER, V71, pP71
[90]   Association of the P-glycoprotein transporter MDR1C3435T polymorphism with the susceptibility to renal epithelial tumors [J].
Siegsmund, M ;
Brinkmann, U ;
Schäffeler, E ;
Weirich, G ;
Schwab, M ;
Eichelbaum, M ;
Fritz, P ;
Burk, O ;
Decker, J ;
Alken, P ;
Rothenpieler, U ;
Kerb, R ;
Hoffmeyer, S ;
Brauch, H .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1847-1854